For example, a retrospective study in Japanese patients with chronic myeloid leukemia supported the proportion of patients with hyperbilirubinemia was significantly higher among patients with the UGT1A1*6/*6 and *6/*28 genotypes than among those with other genotypes44. This evidence concerns the gene UGT1A1 and Hyperbilirubinemia.